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Abstract
The maxilla and masseter muscles are components of the stomatognathic system involved in chewing, which is frequently af-
fected by physical forces such as gravity, and by dental, orthodontic and orthopedic procedures. Thyroid hormones (TH) are 
known to regulate the expression of genes that control bone mass and the oxidative properties of muscles; however, little is 
known about the effects of TH on the stomatognathic system. This study investigated this issue by evaluating: i) osteoprotegerin 
(OPG) and osteopontine (OPN) mRNA expression in the maxilla and ii) myoglobin (Mb) mRNA and protein expression, as well 
as fiber composition of the masseter. Male Wistar rats (~250 g) were divided into thyroidectomized (Tx) and sham-operated (SO) 
groups (N = 24/group) treated with T3 or saline (0.9%) for 15 days. Thyroidectomy increased OPG (~40%) and OPN (~75%) 
mRNA expression, while T3 treatment reduced OPG (~40%) and OPN (~75%) in Tx, and both (~50%) in SO rats. Masseter 
Mb mRNA expression and fiber type composition remained unchanged, despite the induction of hypo- and hyperthyroidism. 
However, Mb content was decreased in Tx rats even after T3 treatment. Since OPG and OPN are key proteins involved in the 
osteoclastogenesis inhibition and bone mineralization, respectively, and that Mb functions as a muscle store of O2 allowing 
muscles to be more resistant to fatigue, the present data indicate that TH also interfere with maxilla remodeling and the oxidative 
properties of the masseter, influencing the function of the stomatognathic system, which may require attention during dental, 
orthodontic and orthopedic procedures in patients with thyroid diseases.
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The activity of bone cells is regulated by mechanical and 
hormonal factors (1). Thyroid hormones (TH) are known 
to participate in bone turnover and their effects have been 
well established (2).
The expression of proteins such as osteoprotegerin 
(OPG) and osteopontine (OPN), is reduced by TH (3,4), 
in contrast to osteocalcin, alkaline phosphatase and bone 
morphogenetic proteins, whose expression is increased 
(5-7). However, the action of TH is more effective on bone 
resorption than synthesis, explaining the bone mass loss 
observed in hyperthyroid states (8). 
Bone resorption is associated with decreased OPG and 
OPN expression. OPG is a member of the transforming 
growth factor (TGF-β) protein superfamily released from 
osteoblasts and capable of blocking osteoclastogenesis 
(9). OPN is an extracellular matrix protein synthesized and 
released from osteoblasts and osteocytes, responsible 
for maintaining calcium in the bone matrix, an essential 
event for mineralization (10). Moreover, it presents a highly 
conserved arginyl-glycyl-aspartic acid motif that mediates 
cell attachment to the extracellular matrix via the alpha V 
beta 3 integrin (11). Some studies also indicate that OPN is 
involved in the regulation of the formation and remodeling of 
mineralized tissue (12). Thus, OPG and OPN are excellent 
markers for the evaluation of the effect of TH on bone.
Most of the studies on TH and bones have been con-
ducted on cultured cells and on the appendicular skeleton 
(13-15). In contrast, few studies have been conducted on the 
effects of TH on bones of the stomatognathic system, such 
as the maxilla, that are involved in chewing and subjected 
to mechanical impact in dental, orthodontic and orthopedic 
procedures, and therefore could be a potentially important 
T3 and stomatognathic system 695
www.bjournal.com.br Braz J Med Biol Res 44(7) 2011
subject for investigation. 
Skeletal muscles are also known to be targeted by TH. 
They can be divided into slow or fast type, depending on 
whether they express type I or type II myosin heavy chain 
(MHC-I or MHC-II) proteins, respectively, and into oxidative 
or glycolytic muscles according to their metabolic character-
istics (16). Among other proteins, oxidative muscles present 
a high content of myoglobin (Mb), a protein that functions as 
a muscle store of O2 (17,18) and as a scavenger of reactive 
oxygen species and nitric oxide (19), causing them to be 
more fatigue resistant. 
TH increase MHC-II and Mb expression in skeletal 
muscle. This effect is more pronounced in soleus muscle 
(20), which is considered to be an anti-gravity muscle, as 
the masseter, which is a component of the stomatognathic 
system involved in chewing. The masseter is a sexually di-
morphic muscle that consists of type II fibers (21), in which 
the effects of TH have not been properly evaluated.
In view of these considerations, the objective of the 
present study was to investigate the effects of TH on OPG 
and OPN gene expression in the maxilla, as well as on 
Mb expression and fiber type in the masseter muscle. 
This investigation might provide some insight into the 
influence of TH specifically on these components of the 
stomatognathic system, resulting in a better assistance in 
dental, orthodontic and orthopedic procedures and buco-
maxillo-facial surgeries.
Material and Methods
Animals and treatments
Male Wistar rats (200-250 g) were obtained from our 
breeding colony and maintained on rat chow and tap 
water ad libitum. They were housed in a room kept at a 
constant temperature of 23 ± 1°C and on a 12-h light/12-h 
dark schedule (lights on at 7:00 am). Some (N = 24) of the 
animals were subjected to surgical thyroidectomy (Tx rats) 
after being deeply anesthetized with ketamine and xylazine 
(100 and 10 mg/kg body, respectively), and received 0.03% 
methylmercaptoimidazole plus 4.5 mM calcium chloride 
in drinking water for 20 days, while others (N = 24) were 
sham-operated (SO). Both experimental groups were 
subjected to T3 treatment (5 µg/100 g body weight, ip) or 
saline for 15 days and were assigned to the SO, Tx, SO 
T3, or Tx T3 groups (N = 12/group). The animals were then 
killed by decapitation and blood was collected for evalu-
ation of total serum T3 concentration with a commercial 
radioimmunoassay kit (Diagnostics Products Corporation, 
USA), using a standard curve prepared by adding different 
concentrations of T3 to iodothyronine-free rat serum. The 
maxilla and masseter muscles were excised and used for 
the analysis of OPG and OPN by conventional polymerase 
chain reaction (PCR), and Mb gene expression by Northern 
and Western blotting analysis. The myosin ATPase activity 
of masseter fibers was determined by histochemistry. Four 
animals per group were used in each experiment, which 
was performed three times, for a total of 48 animals.
The experimental protocol followed the ethical principles 
for animal research adopted by the Brazilian College of 
Animal Experimentation and was approved by the Ethics 
Committee for Animal Research of Instituto de Ciências 
Biomédicas, Universidade de São Paulo.
Reverse transcriptase and PCR
Amplification of OPG and OPN transcripts. Frozen 
maxillaries were thawed and subjected to RNA extraction 
and semi-quantitative RT-PCR analysis. Total RNA was 
extracted with Trizol reagent (Invitrogen, USA) following 
manufacturer instructions (22). The first cDNA was synthe-
sized from 2 µg RNA using oligo-dT primers and the M-MLV 
reverse transcriptase kit (Invitrogen). PCR amplification 
was performed using 1.5 μL of each reverse transcription 
product. The sense and antisense primers used were: 
GAGGATAAAACGGAGACACAG and GGCTGATCTTCTT 
CCCAGGC for OPG and GATAGTGCAGAGCGGTCGGA 
and CAAGCAGTTAGTATTCCTGCTT for OPN. The reac-
tion conditions consisted of denaturation at 95°C for 2 min, 
annealing for 30 s at 54°C for OPG, and 56°C for OPN, and 
amplification at 72°C for 30 s. The number of cycles was 
35 for OPG and 30 for OPN. The effectiveness of PCR was 
evaluated by electrophoresis of PCR products on agarose 
gel stained with ethidium bromide. The bands were analyzed 
by densitometry using the Scion Image software (ScionCorp, 
USA). The endogenous control of the PCR assay was 
the EIFLA constitutive gene whose primer sequence was 
TGCCGTGGTTCAAGGGATG for sense and GCTGCTTCC 
ATTGGTGGGTC for antisense; the annealing temperature 
and number of cycles were 57.7°C and 34, respectively. 
Results are reported as arbitrary units (AU).
Analysis of Mb gene expression
Total masseter RNA was extracted by the method of 
Chomczynski and Sacchi (23) and subjected to Northern 
blotting analysis as described previously (20,24). The 
variability of RNA loading was corrected by membrane 
rehybridization with a 32P-labeled RNA probe specific for 
18S ribosomal RNA (18S c-rRNA), synthesized by in vitro 
transcription (Maxi Script in vitro transcription kit, USA). The 
results are reported as means ± SEM of the Mb mRNA/18S 
rRNA ratio. 
Analysis of Mb protein expression
Protein was extracted from the masseter muscle, 
quantified by the Bradford method (25) (Bio-Rad Protein 
Assay, Dye Reagent Concentrate, USA) and subjected 
to Western blotting by the method of dos Santos et al. 
(20) and Giannocco et al. (24). The blots were analyzed 
by scanning densitometry and quantified using the Image 
Master-1D-Pharmacia Biotech SW software (Pharmacia 
Biotech, Sweden). The data are reported as AU.
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Myosin isoform identification in masseter muscle fibers
This study was performed by determining myofibrillar 
adenosine triphosphatase (mATPase) activity by histochem-
istry using a method adapted from Tuxen and Kirkeby (26). 
Masseter muscle, which had been frozen in isopentane and 
liquid nitrogen, was cut into 10-μm thick histological sections 
and placed on slides for the analysis of myosin ATPase 
activity. After fixation with formol-calcium and confirmation 
of their integrity by toluidine blue staining, the sections were 
incubated in 30 mM sodium acetate, 0.2% glacial acetic acid 
and 16 mM CaCl2, pH 4.3, or in 50 mM glycine, 50 mM NaCl, 
38 mM CaCl2 and 47 mM NaOH, pH 10.3, solutions for 10 
min at room temperature, followed by incubation with glycine 
buffer containing 3 mM ATP for 35 min at room temperature. 
The sections were washed, mounted with glycine jelly, and 
visualized under a Nikon microscope (Nikon Eclipse E 1000, 
USA). The masseter muscle fiber type was then classified 
and the images were captured with the Image Pro-Plus 
software (Media Cybernetic, USA).
Statistical analysis
Data are reported as means ± SEM and the level of 
significance was set at 5% (P < 0.05). Statistical analysis 
was performed by two- or three-way analysis of variance 
(ANOVA) followed by the Bonferroni post-test. 
Results
The effectiveness of Tx and of T3 treatment was con-
firmed by determining the serum T3 concentration and body 
weight of the animals. As expected, Tx rats showed reduced 
serum T3 levels and body weight. Tx and SO rats treated 
with T3 for 15 days presented increased serum T3 concen-
trations, with no changes in body weight (Table 1).
Effect of thyroid hormone on the OPG and OPN gene 
expression in the maxilla
The effect of TH on OPG mRNA expression in the max-
illa is presented in Figure 1A, which shows that Tx induced 
a 40% increase in OPG mRNA content (vs SO), and that 
T3 treatment reduced it to SO levels. Euthyroid (SO) rats 
subjected to T3 treatment also presented reduced OPG 
mRNA content (~60%).
Figure 1B shows that OPN mRNA levels are regulated 
Figure 1. Triiodothyronine (T3) decreases osteoprotegerin (OPG) and osteopontine (OPN) mRNA expression in the rat maxilla. Panels 
A and B show the OPG and OPN mRNA content, respectively, in the maxilla of sham-operated (SO), thyroidectomized (Tx), sham-
operated T3-treated (SO T3), and Tx rats chronically treated with T3 (Tx T3). The T3 dose used was 5 μg/100 g body weight for 15 
days. Typical representative images of OPG, OPN and EIFLA gene expression are given at the top of the panels. Three experiments 
were performed with 4 animals per group (N = 48). Data are reported as means ± SEM, expressed in arbitrary units (AU), and were 
analyzed by two-way analysis of variance (ANOVA), followed by the Bonferroni post-test. *P < 0.0001 vs SO; **P < 0.0001 vs SO T3; 
#P < 0.0001 vs Tx T3; ##P < 0.0001 vs SO.
Table 1. Effect of triiodothyronine (T3) on body weight and serum T3 levels of sham-operated and thyroidec-
tomized rats.
SO SO T3 Tx Tx T3
Body weight (g)
Day 0 298.54 ± 13.22 308 ± 6.37 236.91 ± 10.56 236.8 ± 8.58
Day 15 303.97 ± 12.65 301.35 ± 6.88 219.82 ± 4.88 238.15 ± 6.12
Total T3 serum concentration (ng/mL) 0.35 ± 0.03 0.61 ± 0.19* 0.17 ± 0.01*## 0.56 ± 0.03#
Data are reported as means ± SEM. SO = sham-operated rats; SO + T3 = sham-operated rats treated with T3; 
Tx = thyroidectomized rat; Tx + T3 = thyroidectomized rat treated with T3. Body weight data were analyzed by 
three-way ANOVA and serum T3 values were analyzed by two-way ANOVA. *P < 0.05 vs SO, #P < 0.05 vs SO 
+ T3, ##P < 0.05 vs Tx + T3. N = 9 to 13 rats per group. 
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by TH in a similar fashion as OPG, since Tx increased sig-
nificantly OPN gene expression and T3 treatment restored 
it to SO levels. T3 treatment was shown to reduce OPN 
mRNA content in SO rats as well. 
Effect of thyroidectomy on Mb mRNA and protein 
expression in masseter muscle
The effect of TH on masseter Mb mRNA and protein 
expression is shown in Figure 2A and B, respectively. Tx 
Figure 3. Effect of triiodothyronine (T3) on masseter muscle fiber types. Serial cross-sections of the masseter muscle 
from sham-operated (SO), thyroidectomized (Tx), sham-operated T3-treated (SO T3), and Tx rats chronically treated with 
T3 (Tx T3) illustrating the histochemical stains for myosin ATPase activity. The amount of T3 used was 5 μg/100 g body 
weight, for 15 days. Fiber types are identified as type I and II based on myosin ATPase histochemistry using different pre-
incubation at different pH, namely 4.3 (Panel A) and 10.3 (Panel B). Type II fibers show myosin ATPase activity at alkaline 
pH (alkaline-resistant fibers: dark fibers) and absence of it at acid pH (acid-labile fibers: light fibers). Five animals per group 
were used. Bars = 100 μm.
Figure 2. Effect of thyroidectomy on myoglobin (Mb) mRNA and protein expression in rat masseter muscle. Panels A and B show the 
Mb mRNA and protein content, respectively, in masseter muscle of sham-operated (SO), thyroidectomized (Tx), sham-operated T3-
treated (SO T3), and Tx rats chronically treated with T3 (Tx T3). The T3 dose used was 5 μg/100 g body weight, for 15 days. Typical 
representative blots of Mb and 18S transcripts (A) and Mb protein (B) are given at the top of the panels. Three experiments were per-
formed with 4 animals per group (N = 48). Data are reported as means ± SEM, expressed in arbitrary units (AU), and were analyzed 
by two-way analysis of variance (ANOVA), followed by the Bonferroni post-test. *P < 0.05 vs SO and SO T3.
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rats did not show any alteration in Mb mRNA expression, 
even after T3 treatment. The same occurred with the SO 
animals subjected to T3 treatment (Figure 2A). However, 
Mb protein expression was decreased in Tx rats and was 
not altered by T3 treatment. T3 treatment also did not 
change the Mb protein content in the masseter muscle of 
SO rats (Figure 2B). 
Effect of thyroid hormone on masseter muscle fiber 
types
Myosin ATPase activity was determined in masseter 
muscle sections of control (SO) and Tx rats subjected or 
not to chronic T3 treatment (SO T3; Tx T3). The results are 
shown in Figure 3, in which Panels A and B illustrate the 
myosin ATPase activity of the fibers that were pre-incubated 
at acid or alkaline pH, respectively. It was observed that 
myosin ATPase activity was absent in A, and present in 
B, confirming that the masseter muscle presents a higher 
expression of type II fibers, which are supposed to be fast-
twitch, acid-labile and alkaline-resistant fibers. At pH 4.3 and 
pH 10.3, this pattern of myosin ATPase activity expression 
was not changed by thyroidectomy and T3 treatment. 
Discussion
In the present study, we used the maxilla and masseter 
muscles to evaluate the effects of TH on the stomatognathic 
system. We have shown that thyroidectomy increased the 
expression of OPG and OPN genes and that T3 adminis-
tration for 15 days decreased it, clearly indicating that TH 
exerts a major effect on maxilla resorption. These findings 
support literature data indicating a negative regulation of 
these genes by TH (27-29), and should be considered when 
hyperthyroid patients are subjected to surgical, orthodontic 
and orthopedic procedures.
In fact, local OPG application decreases the movement 
of the teeth during orthodontic manipulations (30), whereas 
TH have been shown to enhance tooth movement (31). 
These data suggest a relationship between OPG and TH, 
which had not been previously investigated. The results of 
the present study suggest a decrease of OPG and OPN 
gene expression during hyperthyroidism. This may explain 
the increase in tooth movement after TH administration, 
since they induce loss of bone mass.
Concerning the masseter, which is an anti-gravity mus-
cle, as expected, we observed a higher expression of type 
II fibers (26). This contrasts with other anti-gravity muscles 
such as the soleus, which present a predominance of type 
I fibers and higher Mb expression, and where TH increase 
the expression of type II fibers and Mb (20).
In the present study, the fiber type and Mb content of 
the masseter muscle were unchanged by T3 administration. 
Even though the methodology employed to classify the 
fibers has certain limitations (32), the results obtained by 
T3 treatment were somehow expected, since T3 is known 
to increase type II fibers in skeletal muscle (33). However, 
thyroidectomy was shown to reduce Mb content and T3 
treatment was unable to restore it to control levels. It is 
very interesting that masseter muscle has been shown to 
be refractory to excess TH administration, even though it 
presented a decrease in the Mb protein content, in hypothy-
roidism, which could result from the reduced metabolic rate 
observed in this condition (34). It is possible that its diverse 
embryological origin might account for this result. In addi-
tion, the masseter is a sexually dimorphic muscle, and this 
kind of muscle has been shown to present low expression 
of TH receptors or a reduced affinity of TH receptors for T3 
(35,36), which could explain its insensitivity to TH adminis-
tration. In fact, no differences in fiber types were observed 
in masseter muscle after either hypo- or hyperthyroidism 
induction, a fact that supports our hypothesis. 
Even though further studies are needed to define bet-
ter the relationship between TH and masseter muscle, it is 
possible to infer that chewing is not affected by TH, since 
the main muscle involved in this function, the masseter, is 
supposed to be insensitive to excess TH. Nevertheless, 
the maxilla was shown to be strongly affected by TH since 
chronic T3 treatment led to a decrease in OPG and OPN 
gene expression, indicating that bone resorption was taking 
place. This would require more attention on the part of the 
dental surgeon during tooth extraction, bucco-maxillo-facial 
surgeries, and during frequently performed orthodontic and 
orthopedic procedures. 
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